Picture of Commercial International Bank Egypt CIB logo

CBKD Commercial International Bank Egypt CIB News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsAdventurousLarge CapNeutral

Commercial Int Bank - 3rd Quarter Results

RNS Number : 0095G

Commercial Intnl Bank (Egypt) SAE

03 November 2025

 

Condensed Separate Interim Statement of Financial Position as at September 30, 2025
NotesSep. 30, 2025Dec. 31, 2024
Assets
Cash and balances at the central bank1020,916,631136,165,920
Due from banks11228,152,325270,089,441
Loans and advances to banks, net1326,914,8849,555,410
Loans and advances to customers, net14452,110,898340,955,698
Derivative financial instruments1,222,908819,711
Financial investments
- Financial Assets at Fair Value through P&L152,203,869-
- Financial Assets at Fair Value through OCI15329,796,707233,029,903
- Financial Assets at Amortized cost15228,915,634167,276,956
Investments in subsidiaries and associates161,255,421871,525
Non-current assets held for sale30159,828159,828
Other assets1749,915,05644,175,232
Deferred tax assets2,457,4932,337,304
Property and equipment185,470,6423,881,620
Total assets1,349,492,2961,209,318,548
Liabilities and equity
Liabilities
Due to banks197,043,8812,317,715
Due to customers201,043,204,762967,895,387
Derivative financial instruments223,670100,571
Current income tax liabilities15,857,81818,327,968
Other liabilities2126,802,78021,347,499
Issued debt instruments224,779,4615,067,781
Other loans30,249,27823,962,389
Other provisions2314,478,19018,613,060
Total liabilities1,142,639,8401,057,632,370
Equity
Issued and paid capital30,708,51030,431,580
Reserves105,209,97463,125,912
Reserve for employee stock ownership plan (ESOP)2,071,2471,868,235
Retained earnings*68,862,72556,260,451
Total equity and net profit for the period / year206,852,456151,686,178
Total liabilities and equity1,349,492,2961,209,318,548
The accompanying notes are an integral part of these financial statements.
(Review report attached)
*Including net profit for the period
 
Condensed Separate Interim Income Statement for the period ended September 30, 2025
Last 9 MonthsLast 9 Months
NotesSep. 30, 2025Sep. 30, 2024
Interest and similar income157,761,416130,537,149
Interest and similar expense(79,403,286)(65,010,779)
Net interest income78,358,13065,526,370
Fee and commission income11,565,7849,257,495
Fee and commission expense(5,224,939)(4,048,928)
Net fee and commission income6,340,8455,208,567
Dividend income125,185100,858
Net trading income61,276,50218,177,630
Profits (Losses) on financial investments15.1598,228377,992
Administrative expenses(11,880,346)(8,795,429)
Other operating income (expenses)7687,384(17,980,232)
Impairment release (charges) for credit losses97,976,997(3,741,208)
Profit before income tax83,482,92558,874,548
Income tax expense27(21,867,730)(16,964,163)
Deferred tax assets (Liabilities)27592,311646,991
Net profit for the period62,207,50642,557,376
Earnings per share8
Basic18.5412.50
Diluted18.3612.38
 
Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2025
Last 9 MonthsLast 9 Months
Sep. 30, 2025Sep. 30, 2024
Net profit for the period62,207,50642,557,376
Transferred to RE from financial assets at fair value through OCI3,586(370,224)
Net change on financial assets at fair value through comprehensive income after tax6,805,8368,284,110
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income(399,884)624,524
Total comprehensive income for the period68,617,04451,095,786
 
Condensed Separate Interim Cash Flows for the period ended September 30, 2025
NotesSep. 30, 2025Sep. 30, 2024
Cash flow from operating activities
Profit before income tax83,482,92558,874,548
Adjustments to reconcile profits to net cash provided by operating activities
Fixed assets depreciation181,244,370763,079
Impairment release/charge for credit losses (Loans and advances to customers and banks)9(7,980,073)4,226,051
Net charged/released for other provisions23(4,080,370)429,182
Impairment release/charge for credit losses (due from banks)9151,236(5)
Impairment release/charge for credit losses (financial investments)9(148,160)(484,838)
Impairment release/charge for other assets-(11,956)
Exchange revaluation differences for financial assets at fair value through OCI and AC4,669,694(18,536,183)
Revaluation differences impairment charge for Financial Assets at Fair value through OCI(225,004)1,199,896
Revaluation differences impairment charge for Financial Assets at Amortized cost(16,709)107,207
Revaluation differences impairment charge for due from banks(7,813)107
Net utilized/recovered for other provisions23(2,039)(9,196)
Exchange revaluation differences of other provisions23(52,461)3,963,023
Profits/losses from selling property and equipment(8,006)(2,254)
Profits/losses from selling financial investments at fair value through OCI15.1(416,668)(377,992)
Profits/losses from selling investments in associates15.1(181,560)-
Share based payments990,324804,345
Operating profits before changes in operating assets and liabilities77,419,68650,945,014
Net decrease / increase in assets and liabilities
Due from banks158,353,929(24,748,544)
Financial assets at fair value through P&L(2,203,869)(2,066,889)
Derivative financial instruments(306,569)(229,127)
Loans and advances to banks and customers(120,567,170)(74,803,105)
Other assets(2,706,703)(14,036,648)
Due to banks194,726,166(8,606,431)
Due to customers2075,309,375221,382,197
Current income tax obligations paid(6,009,912)(2,694,657)
Other liabilities(12,872,687)(6,305,033)
Net cash generated from (used in) operating activities171,142,246138,836,777
Cash flow from investing activities
Proceeds from sale of investments in associates339,92011,956
Payments for investment in subsidiaries(542,256)(200,000)
Payments for purchases of property, equipment and branches construction(5,833,944)(2,284,236)
Proceeds from selling property and equipment78,0062,254
Proceeds from redemption of financial assets at amortized cost21,249,0231,093,724
Payments for purchases of financial assets at amortized cost(83,115,289)(105,723,312)
Payments for purchases of financial assets at fair value through OCI(192,334,673)(21,646,713)
Proceeds from selling financial assets at fair value through OCI98,063,75267,015,091
Net cash generated from (used in) investing activities(162,165,461)(61,731,236)
Condensed Separate Interim Cash Flows for the period ended September 30, 2025 (Cont.)
Sep. 30, 2025Sep. 30, 2024
Cash flow from financing activities
Other loans6,286,8897,840,786
Dividends(14,714,434)(5,078,792)
Issued debt instruments(288,320)1,738,393
Capital increase276,930236,570
Net cash generated from (used in) financing activities(8,438,935)4,736,957
Net (decrease) increase in cash and cash equivalent during the period537,85081,842,498
Beginning balance of cash and cash equivalent227,028,744233,912,193
Cash and cash equivalent at the end of the period227,566,594315,754,691
Cash and cash equivalent comprise:
Cash and balances at the central bank1020,916,63194,285,689
Due from banks228,295,965304,041,410
Treasury bills and other governmental notes12140,546,84082,174,775
Obligatory reserve balance with CBE(2,725,245)(76,128,521)
Due from banks with maturity more than three months(19,202,757)(17,846,556)
Treasury bills and other governmental notes with maturity more than three months(140,264,840)(70,772,106)
Total cash and cash equivalent227,566,594315,754,691
   
Condensed Separate Interim statement of changes in shareholders' equity
Issued and paid capitalLegal reserveGeneral reserveGeneral risk reserveSpecial reserveCapital reserveReserve for financial assets at fair value through OCIBanking risks reserveRetained earningsReserve for employee stock ownership planTotal
Sep. 30, 2024
Beginning Balance at 1 January 202430,195,0104,770,35439,840,7071,549,445-21,155(16,808,265)15,23029,230,3601,486,01090,300,006
Capital increase236,570---------236,570
Transferred to reserves-1,438,32022,582,085--1,663--(23,398,943)(623,125)-
Dividend paid--------(5,366,429)-(5,366,429)
Net profit for the period--------42,557,376-42,557,376
Transferred to RE from financial assets at fair value through OCI------(370,224)-370,224--
Net change on financial assets at fair value through OCI after tax------8,284,110---8,284,110
Transferred (from) to banking risk reserve-------2,694(2,694)--
Effect of ECL on debt instruments measured at fair value through OCI------624,524---624,524
Cost of employees stock ownership plan (ESOP)---------804,345804,345
Balance at 30 September 202430,431,5806,208,67462,422,7921,549,445-22,818(8,269,855)17,92443,389,8941,667,230137,440,502
Issued and paid capitalLegal reserveGeneral reserveGeneral risk reserveSpecial reserveCapital reserveReserve for financial assets at fair value through OCIBanking risks reserveRetained earningsReserve for employee stock ownership planTotal
Sep. 30, 2025
Beginning Balance at 1 January 202530,431,5806,208,67462,422,7921,549,445-22,818(7,095,741)17,92456,260,4511,868,235151,686,178
Capital increase276,930---------276,930
Transferred to reserves-2,771,28419,758,610--2,246--(21,744,828)(787,312)-
Dividends paid--------(14,714,434)-(14,714,434)
Net profit for the period--------62,207,506-62,207,506
Transferred to RE from financial assets at fair value through OCI------3,586-(3,586)--
Transferred from net profit to special reserve----13,145,012---(13,145,012)--
Net change on financial assets at fair value through OCI after tax------6,805,836---6,805,836
Transferred (from) to banking risk reserve-------(2,628)2,628--
Effect of ECL on debt instruments measured at fair value through OCI------(399,884)---(399,884)
Cost of employees stock ownership plan (ESOP)---------990,324990,324
Balance at 30 September 202530,708,5108,979,95882,181,4021,549,44513,145,01225,064(686,203)15,29668,862,7252,071,247206,852,456
        This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     QRTUPGGWGUPAGBW

Recent news on Commercial International Bank Egypt CIB

See all news